These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29058038)

  • 1. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis.
    Zheng WY; Richardson LC; Li L; Day RO; Westbrook JI; Baysari MT
    Eur J Clin Pharmacol; 2018 Jan; 74(1):15-27. PubMed ID: 29058038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation.
    Li L; Baker J; Quirk R; Deidun D; Moran M; Salem AA; Aryal N; Van Dort BA; Zheng WY; Hargreaves A; Doherty P; Hilmer SN; Day RO; Westbrook JI; Baysari MT
    Drug Saf; 2024 Jun; 47(6):557-569. PubMed ID: 38478349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
    Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
    PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
    Dechanont S; Maphanta S; Butthum B; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
    Straubhaar B; Krähenbühl S; Schlienger RG
    Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions in pediatric oncology patients.
    Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
    BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C; Prado N; Acurcio F
    Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
    Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
    Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments.
    Fokter N; Mozina M; Brvar M
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):81-8. PubMed ID: 20213374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature.
    Nabovati E; Vakili-Arki H; Taherzadeh Z; Hasibian MR; Abu-Hanna A; Eslami S
    Daru; 2014 Jun; 22(1):52. PubMed ID: 24965959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine.
    Vonbach P; Dubied A; Krähenbühl S; Beer JH
    Eur J Intern Med; 2008 Oct; 19(6):413-20. PubMed ID: 18848174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis assessing the prevalence of drug-drug interactions among hospitalized patients.
    Aksoy N; Ozturk N
    Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1319-1330. PubMed ID: 37705139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of drug interactions in hospitalised elderly patients: a systematic review.
    de Oliveira LM; Diel JDAC; Nunes A; da Silva Dal Pizzol T
    Eur J Hosp Pharm; 2021 Jan; 28(1):4-9. PubMed ID: 33355278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review.
    Sutherland A; Phipps DL; Tomlin S; Ashcroft DM
    BMC Pediatr; 2019 Dec; 19(1):486. PubMed ID: 31829142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study.
    Ismail M; Noor S; Harram U; Haq I; Haider I; Khadim F; Khan Q; Ali Z; Muhammad T; Asif M
    BMC Health Serv Res; 2018 Oct; 18(1):762. PubMed ID: 30314487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
    Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
    Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
    Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.